These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22834145)

  • 1. [The ability of small interfering RNA oligonucleotides to decrease the infective activity of hepatitis C virus in the cell cultures].
    Bavykin AS; Mishin DV; Karpukhin AV; Deriabin PG
    Vopr Virusol; 2012; 57(2):32-4. PubMed ID: 22834145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiviral activity of polyprenylphosphates in experimental infection caused by hepatitis C virus in vitro].
    Narovlianskiĭ AN; Deriabin PG; Sedov AM; Sanin AV; Pronin AV
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (5):81-4. PubMed ID: 23163044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAT peptides mediated small interfering RNA delivery to Huh-7 cells and efficiently inhibited hepatitis C virus RNA replication.
    Meng S; Wei B; Xu R; Zhang K; Wang L; Zhang R; Li J
    Intervirology; 2009; 52(3):135-40. PubMed ID: 19478527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small interfering RNA targeted to hepatitis C virus 5' nontranslated region exerts potent antiviral effect.
    Kanda T; Steele R; Ray R; Ray RB
    J Virol; 2007 Jan; 81(2):669-76. PubMed ID: 17079316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatitis C virus replication by single and dual small interfering RNA using an HCV-infected cell model.
    Xing XK; Li SJ; He JL; Chen Z
    Biotechnol Lett; 2012 Feb; 34(2):295-301. PubMed ID: 21972147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galactosylated Lipidoid Nanoparticles for Delivery of Small Interfering RNA to Inhibit Hepatitis C Viral Replication In Vivo.
    Park HJ; Jeon EJ; Lee JS; Hong SH; Cho AN; Lee J; Moon JS; Jung KE; Oh JW; Lee H; Cho SW
    Adv Healthc Mater; 2016 Nov; 5(22):2931-2941. PubMed ID: 27774775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hepatitis C virus genotype 4 replication using siRNA targeted to the viral core region and the CD81 cellular receptor.
    Aljowaie RM; Almajhdi FN; Ali HH; El-Wetidy MS; Shier MK
    Cell Stress Chaperones; 2020 Mar; 25(2):345-355. PubMed ID: 32060691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.
    Saito K; Shirasago Y; Suzuki T; Aizaki H; Hanada K; Wakita T; Nishijima M; Fukasawa M
    J Virol; 2015 Feb; 89(4):2220-32. PubMed ID: 25473062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatitis viral replication by siRNA.
    Wu J; Nandamuri KM
    Expert Opin Biol Ther; 2004 Oct; 4(10):1649-59. PubMed ID: 15461576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference targeting nucleocapsid protein (C) inhibits classical swine fever virus replication in SK-6 cells.
    Porntrakulpipat S; Supankong S; Chatchawanchonteera A; Pakdee P
    Vet Microbiol; 2010 Apr; 142(1-2):41-4. PubMed ID: 19850420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of hepatitis C virus replication by small interfering RNA in cells infected by HCV].
    Xing XK; He JL; Chen Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 40(6):582-7. PubMed ID: 22190516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positional effects and strand preference of RNA interference against hepatitis C virus target sequences.
    Smith RM; Smolic R; Volarevic M; Wu GY
    J Viral Hepat; 2007 Mar; 14(3):194-212. PubMed ID: 17305886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
    Chen C; Qiu H; Gong J; Liu Q; Xiao H; Chen XW; Sun BL; Yang RG
    Arch Virol; 2012 Jul; 157(7):1301-12. PubMed ID: 22491814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
    Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
    Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
    Guedj J; Neumann AU
    J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells.
    Mizutani T; Kato N; Hirota M; Sugiyama K; Murakami A; Shimotohno K
    Biochem Biophys Res Commun; 1995 Jul; 212(3):906-11. PubMed ID: 7626129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
    Kim M; Shin D; Kim SI; Park M
    Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of Pycnogenol® on hepatitis C virus replication.
    Ezzikouri S; Nishimura T; Kohara M; Benjelloun S; Kino Y; Inoue K; Matsumori A; Tsukiyama-Kohara K
    Antiviral Res; 2015 Jan; 113():93-102. PubMed ID: 25446333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.